SEC
Whistleblower
Advocates

February 04, 2016

SciClone Pharmaceuticals

Foreign Corrupt Practices Act

SANCTION AMOUNT: $12,826,000

Defendants: SciClone Pharmaceuticals

Settlement of charges that SciClone Pharmaceuticals violated the FCPA when international subsidiaries increased sales by making improper payments to health care professionals employed at state health institutions in China.

Thank you for submitting some email to us.